Recent Posts
Connect with:
Saturday / July 13.


Many people with dry eye disease do not achieve sufficient relief with over-the-counter eye drops.

Cequa (ciclosporin 900 microgram/mL) eye drops are a novel formulation of ciclosporin indicated to increase tear production in patients with moderate to severe keratoconjunctivitis sicca (dry eye) where prior use of artificial tears has not been sufficient.1

Cequa has been engineered using a unique nanomicelle technology to deliver ciclosporin where it’s needed most2-5 and has been found to significantly reduce corneal staining at 28 days vs. vehicle (p<0.01).2

Patient starter packs of Cequa are available containing 10 ampoules by emailing [email protected]


This medicinal product is subject to additional monitoring in Australia. This will allow quick identification of new safety information.

Healthcare professionals are asked to report any suspected adverse events at www.tga.gov.au/reporting-problems.

Contact: Sun Pharma (AUS) 1800 726 229

Date of preparation: January 2023CEQ01/2023MIVI


  1. Cequa Approved Product Information. 2. Goldberg D.F., et al., Ophthalmology 2019; 126:1230–7. 3. Tauber J. et al.,. Clin Ophthalmol 2018; 12:1921–9.
  2. Vaishya R. et al.,. Wiley Interdisciplin Rev Nanomed Nanobiotechnol 2014; 6:422–37. 5. Weiss S.L. et al., J Ocul Pharmacol Ther 2019; 35:395–402.

This article is restricted to
Verified Health Practitioners only

Already registered?